Buy Regeneron - Cramer's Lightning Round (12/14/17)

|
Includes: ACOR, ATVI, BA, EA, OC, REGN, TMUS, TTWO
by: SA Editor Mohit Manghnani
Summary

Boeing could reach $400 in 18-24 months.

Don't buy Acorda Therapeutics.

Wait for Owens Corning to pull back before buying.

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Thursday, December 14.

Bullish Calls

T-Mobile (NASDAQ:TMUS): "CEO John Legere made an acquisition, and frankly, I'm puzzled by it. I like T-Mobile. I did not understand this video acquisition. John, come on this show and explain it to us."

Electronic Arts (NASDAQ:EA): It's a good stock but Cramer prefers Take-Two Interactive (NASDAQ:TTWO) and Activision Blizzard (NASDAQ:ATVI).

Regeneron Pharmaceuticals (NASDAQ:REGN): It's doing great things but not getting credit for it. Buy it.

Boeing (NYSE:BA): Don't sell Boeing as it has $400 target in 18-24 months.

Bearish Calls

Acorda Therapeutics (NASDAQ:ACOR): No. There are other high-quality stocks out there.

Owens Corning (NYSE:OC): It's a good stock but is up 66% in a straight line. Wait for a pullback before buying.

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Jim Cramer's Action Alerts PLUS: Check out Cramer's multi-million dollar charitable trust portfolio and uncover the stocks he thinks could be HUGE winners. Start your FREE 14-day trial now!

Get Cramer's Picks by email - it's free and takes only a few seconds to sign up